Cepeginterferon alfa-2B
- Generic Name
- Cepeginterferon alfa-2B
- Brand Names
- -
- Drug Type
- Biotech
- Chemical Formula
- -
- CAS Number
- 1192706-52-7
- Unique Ingredient Identifier
- 6J022WTC4Y
- Background
Cepeginterferon alfa-2B is under investigation in clinical trial NCT01889433 (An Open-label Comparative Efficacy and Safety Study of Algeron (Cepeginterferon Alfa-2b) in Treatment-naive Patients With Chronic Hepatitis C).
- Associated Conditions
- -
- Associated Therapies
- -
An Open-label Randomized Multicenter Phase III Clinical Study Comparing Safety and Efficacy of Algeron (Cepeginterferon Alfa-2b) and and PegIntron (Peginterferon Alfa-2b) in Combination With Ribavirin as Combined Treatment of Chronic Hepatitis C in Human Immunodeficiency Virus-1 Infected Patients
- Conditions
- Interventions
- First Posted Date
- 2014-04-03
- Last Posted Date
- 2018-08-09
- Lead Sponsor
- Biocad
- Target Recruit Count
- 140
- Registration Number
- NCT02103439
- Locations
- 🇷🇺
State Institution of Nizhny Novgorod region "Regional Center for Prevention and Control of AIDS and other infectious diseases", Nizhny Novgorod, Russian Federation
🇷🇺State Budgetary Higher Vocational Education Institution Pacific State Medical University, Ministry of Health of the Russian Federation, Vladivostok, Russian Federation
🇷🇺State Public Healthcare Institution National Center for the Prevention and Control of AIDS and other infectious diseases of the Ministry of Health of the Republic of Tatarstan, Kazan, Republic Of Tatarstan, Russian Federation
An Open-label Comparative Efficacy and Safety Study of Algeron (Cepeginterferon Alfa-2b) in Treatment-naive Patients With Chronic Hepatitis C
- First Posted Date
- 2013-06-28
- Last Posted Date
- 2018-07-16
- Lead Sponsor
- Biocad
- Target Recruit Count
- 170
- Registration Number
- NCT01889433
- Locations
- 🇮🇳
M V Hospital & Research Center, Lucknow, India
🇮🇳Medipoint Hospitals Pvt. Ltd., Pune, India
🇷🇺State Budgetary Higher Vocational Education Institution I.M. Sechenov First Moscow State Medical University, Moscow, Russian Federation
Algeron (Cepeginterferon Alfa-2b) Compared With PegIntron (Peginterferon Alfa-2b) for Treatment of Chronic Hepatitis C
- Conditions
- Interventions
- First Posted Date
- 2012-12-04
- Last Posted Date
- 2015-08-18
- Lead Sponsor
- Biocad
- Target Recruit Count
- 150
- Registration Number
- NCT01740089
- Locations
- 🇷🇺
Moscow State University of Medicine and Dentistry, Moscow, Russian Federation
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.